1AD 0.00% 2.7¢ adalta limited

Biotech Ripper to Accumulate

  1. 2,092 Posts.
    lightbulb Created with Sketch. 103
    So path to human trials is relatively short.

    Four week toxicology study. Results due between now and Dec. These may come early

    Human Trials
    Phase 1 study to commence early Jan. Really very short time frame in biotech terms.

    Strong management team

    Really good chance to accumulate under 25 cents.

    Been stalking this for a couple of years.

    Giddy up!






 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $16.08M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 1187032 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 437561 2
View Market Depth
Last trade - 16.12pm 06/06/2024 (20 minute delay) ?
Last
2.5¢
  Change
0.000 ( 3.85 %)
Open High Low Volume
2.5¢ 2.5¢ 2.5¢ 10000
Last updated 15.55pm 06/06/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.